For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

News Archives

A number of BELIEVE investigators traveled to Paris, France to attend and present at the 9th IAS Conference on HIV Science on July 23-26, 2017. This biennial gathering is the largest open scientific conference on HIV and AIDS related issues - bringing together a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice...

The Guggenheim has become something of a brand over the years, with satellite locations in Venice and Bilbao, Spain, and one planned in Abu Dhabi. Now this museum_s proposed branch in Helsinki, Finland, has taken a step closer to reality, with the selection of a design that features charred timber and glass punctuated by a lighthouse-like tower overlooking South Harbor.

It is still uncertain whether the design...

EDMONTON, Alberta _ It began as a fascinating match of the establishment against the insurgent, an evolutionary tug of war in women_s soccer, with the United States trying to maintain its hold as a traditional power and Colombia trying to break through to a new era of parity.

And for a half on Monday, aspiring Colombia held the Americans scoreless in their round-of-16 game at the Women_s World Cup with a...

Recently, BELIEVE investigators traveled to Mexico City to participate in the 2017 BELIEVE International Symposium. At the symposium, collaborators from the United States, Canada and Mexico met to discuss their most recent research findings within the collaboratory. Several investigators presented their progress and engaged in a productive dialogue about the future of BELIEVE. A primary purpose of this symposium was to increase the synergy between the CIENI international collaborators and...

BELIEVE's first annual meeting took place last week at The Hotel Monaco in Washington, DC. Nearly 100 basic scientists, clinicians, NIH members, and community members attended the two-day meeting to listen to presentations by IRF leaders and support sections about progress and milestones met during Year 1 of the grant. Many attendees traveled from all over the U.S., Canada, Mexico, Brazil, England, and Australia, making for great diversity and networking amongst members of the collaboratory...

The NIH-sponsored International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Network Annual Meeting will be held on May 29 - June 2, 2017 in Washington, DC. 

Brad Jones, Ph.D., was invited to deliver a 25-minute presentation on "cytotoxic T-cell responses to contribute to HIV cure" during...

Congratulations to Yanqin Ren (Post-doctoral Scientist, Jones Lab) and Adam Ward (Research Assistant, Jones Lab) who have been awarded a scholarship to attend and present at the IAS 2017 HIV Cure & Cancer Forum in July! 

Yanqin will be presenting on A subset of bnAbs exhibit broad...

WASHINGTON (April 19, 2017) — Defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV. Researchers at the George Washington University (GW) and Johns Hopkins University publish their findings in Cell Host & Microbe.

Current HIV cure research focuses on eliminating intact proviruses in infected patients. However, the ratio of intact and defective...

By Kristen Mitchell

George Washington University researchers have received a five-year Martin Delaney Collaboratory grant from the National Institutes of Health to develop new strategies to cure HIV, with first-year funding totaling $5.7 million and similar funds planned for each of the subsequent years.

The team will apply immunotherapy...

The National Institutes of Health has awarded approximately $30 million in annual funding over the next five years to six research collaborations working to advance basic medical science toward an HIV cure. The awards comprise the second iteration of the Martin Delaney Collaboratory: Towards an HIV-1 Cure program and are a part of ...

BELIEVE Collaboratory Belfer Research Building, 413 E. 69th St., 5 FL New York, NY 10021 Phone: (646) 962-2478